trending Market Intelligence /marketintelligence/en/news-insights/trending/z2-bIA3kKc6B92tdgLMiTg2 content esgSubNav
In This List

Insulet appoints 2 directors

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Insulet appoints 2 directors

Insulet Corp. appointed Michael Minogue and James Mullen to its board of directors.

The company also said that Regina Sommer and Joseph Zakrzewski retired from the board.

Minogue is CEO, president and chairman of medical device manufacturer ABIOMED Inc.

Mullen is CEO of pharmaceutical contract development and manufacturing organization Patheon N.V., which is in the process of being acquired by Thermo Fisher Scientific Inc.